Skip to main content
SpringerLink
Log in

Mitral Valve Reconstruction in the Patient with Heart Failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Secondary MR is a complication of end-stage cardiomyopathy and is associated with a poor prognosis and is due to progressive mitral annular dilation and alteration in LV geometry. A vicious cycle of continuing volume overload, ventricular dilation, progression of annular dilation, increased LV wall tension and worsening MR and CHF occur. The mainstay of medical therapy is diuretics and afterload reduction, and is associated with poor long-term survival in these patients with CHF and MR. However, surgical intervention in the form of undersized, ‘overcorrecting’ mitral valve repair has shown great promise and is an area of ongoing investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boltwood CM, Tei C, Wong M, Shah PM. Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation. Circulation 1983;68(3):498–508.

    Google Scholar 

  2. Stevenson LW, Fowler MB, Schroeder JS, Stevenson WG, Dracup KA, Fond V. Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. Am J Medicine 1987;83(5):871–876.

    Google Scholar 

  3. Rosario LB, Stevenson LW, Solomon SD, Lee RT, Reimold SC. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol 1998;32:1819–1824.

    Google Scholar 

  4. Fann JI, Ingels NB, Miller DC. Pathophysiology of mitral valve disease and operative indications. In: Edmunds LH, ed. Cardiac Surgery in the Adult. NY: McGraw-Hill, 1997:959–990.

    Google Scholar 

  5. Starling MR, Kirsh MM, Montgomery DG, Gross MD. Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction. J Am Coll Cardiol 1993;22(1):239–250.

    Google Scholar 

  6. Carabello BA, Williams H, Gash AK, Kent R, Belber D, Maurer A, Siegel J, Blasius K, Spann JF. Hemodynamic predictors of outcome in patients undergoing valve replacement. Circulation 1986;74(6):1309–1316.

    Google Scholar 

  7. Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T, Ueda Y, Okada Y, Morioka S, Yoshikawa J. Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery. J Am Coll Cardiol 1998;32:1923–1930.

    Google Scholar 

  8. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DE, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205–211.

    Google Scholar 

  9. Kawaguchi HK, Kitabatake A. Alterations of signal transduction system in heart failure. Japan Heart J 1997;38:317–332.

    Google Scholar 

  10. Harding SE, Brown LA, Wynne DG, Davies CH, Poole-Wilson PA. Mechanisms of β adrenoceptor desensitization in the failing human heart. Cardiovasc Res 1994;28:1451–1460.

    Google Scholar 

  11. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD), J Am Coll Cardiol 1996:27(5):1201–1206.

    Google Scholar 

  12. Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A, Vooletich MT, Farmer JA, Torre-Amione G. Tumor necrosis factor-α: A mediator of disease progression in the failing human heart. Chest 1999;115:1170–1174.

    Google Scholar 

  13. Thomas, JD. How leaky is that mitral valve? Simplified Doppler methods to measure regurgitant orifice area. Circulation 1997;93(3):548–550.

    Google Scholar 

  14. Sarris GE, Cahill PD, Hansen DE, Derby GC, Miller DC. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction. J Thorac Cardiovasc Surg 1988;95(6):969–979.

    Google Scholar 

  15. David TE, Uden DE, Strauss HD. The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation. Circulation 1983;68(3 pt 2):1176–1182.

    Google Scholar 

  16. Huikuri HV. Effect of mitral valve replacement on left ventricular function in mitral regurgitation. Br Heart J 1983;49(4):328–333.

    Google Scholar 

  17. Tischler MD, Cooper KA, Rowen M, LeWinter MM. Myocardial function/valvular heart disease/hypertensive heart disease: mitral valve replacement versus mitral valve repair: a Doppler and quantitative stress echocardiographic study. Circulation 1994;89(1):132–137.

    Google Scholar 

  18. Akins CW, Hilgenberg AD, Buckley MJ, Vlahakes GJ, Torchiana DF, Daggett WM, Austen WG. Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation. Ann Thorac Surg 1994;58:668–676.

    Google Scholar 

  19. Batista R. Partial left ventriculectomy — the Batista procedure. Thorac Surg 1999;15(suppl. 1):S12-S19.

    Google Scholar 

  20. Batista RJV, Verde J, Nery P, Bocchino L, Takeshita N, Bhayana JN, Bergsland J, Graham S, Houck JP, Salerno TA. Partial left ventriculectomy to treat endstage heart disease. Ann Thorac Surg 1997;64:634–638.

    Google Scholar 

  21. McCarthy JF, McCarthy PM, Starling RC, Smedira NG, Scalia GM, Wong J, Kasirajan V, Goormastic M, Young JB. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. Eur J Cardiothorac Surg 1998;13:337–343.

    Google Scholar 

  22. Bolling SF, Deeb GM, Brunsting LA, Bach DS. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 1995;109(4):676–683.

    Google Scholar 

  23. Bolling SF, Pagani FD, Deeb GM, Bach SF. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998;115:381–388.

    Google Scholar 

  24. Anguita M, Arizon JM, Bueno G, Latre JM, Sancho M, Torres F, Gimenez D, Concha M, Valles F. Clinical and hemodynamic predictors of survival in patients aged < 65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1993;72(5):413–417.

    Google Scholar 

  25. Dowling RD, Koenig SC, Ewert DL, Laureano MA, Gray LA. Acute cardiovascular changes of partial left ventriculectomy without mitral valve repair. Ann Thor Surg 1996;67:1470–1472.

    Google Scholar 

  26. Rosario LB, Stevenson LW, Solomon SD, Lee RT, Reimold SC. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol 1998;32:1819–1824.

    Google Scholar 

  27. Fann JI, Ingels NB, Miller DC. Pathophysiology of mitral valve disease and operative indications. In: Edmunds LH, ed. Cardiac Surgery in the Adult. NY: McGrawHill, 1997:959–990.

    Google Scholar 

  28. Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T, Ueda Y, Okada Y, Morioka S, Yoshikawa J. Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery. J Am Coll Cardiol 1998;32:1923–1930.

    Google Scholar 

  29. Kawaguchi HK, Kitabatake A. Alterations of signal transduction system in heart failure. Japan Heart J 1997;38:317–332.

    Google Scholar 

  30. Bohm M. Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure. J Thorac Cardiovasc Surg 1998;46(suppl):270–276.

    Google Scholar 

  31. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DE, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205–211.

    Google Scholar 

  32. Brodde OE. Beta 1-and Beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991;43(2):203–242.

    Google Scholar 

  33. Harding SE, Brown LA, Wynne DG, Davies CH, Poole-Wilson PA. Mechanisms of β-adrenoceptor desensitization in the failing human heart. Cardiovasc Res 1994;28:1451–1460.

    Google Scholar 

  34. Torre-Amione G. The syndrome of heart failure: emerging concepts in the understanding of its pathogenesis and treatment. Current Opinion in Cardiology 1999;14:193–195.

    Google Scholar 

  35. Bohm M. Alterations of beta-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure. Mol Cell Biochem 1995;147(1–2):147–160.

    Google Scholar 

  36. Bohm M, Diet F, Kemkes B, Erdmann E. Enhancement of the effectiveness of milrinone to increase force of contraction by stimulation of cardiac beta-adrenoceptors in the failing human heart. Klinische Wochenschrift 1998;66(19):957–962.

    Google Scholar 

  37. Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 1987;75(2):331–339.

    Google Scholar 

  38. Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest 1992;90:389–398.

    Google Scholar 

  39. Blum A, Miller H. Role of cytokines in heart failure. Am Heart J 1988;135 (2 pt 1):181–186.

    Google Scholar 

  40. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996;27(5):1201–1206.

    Google Scholar 

  41. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236–241.

    Google Scholar 

  42. Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A, Vooletich MT, Farmer JA, Torre-Amione G. Tumor necrosis factor-α: A mediator of disease progression in the failing human heart. Chest 1999;115:1170–1174.

    Google Scholar 

  43. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321(26):1828–1830.

    Google Scholar 

  44. Hagewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet 1990;335(8684):294–295.

    Google Scholar 

  45. Milani RV, Mehra MR, Endres S, Eigler A, Cooper ES, Lavie CJ, Ventura HO. The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. Chest 1996;110(4):992–995.

    Google Scholar 

  46. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies R, Young JB, Mann DL. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93(4):704–711.

    Google Scholar 

  47. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92(6):1479–1486.

    Google Scholar 

  48. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro. Proc Nat Acad Sci 1992;89(11):4845–4849.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Cardiac Surgery, University of Michigan Hospital, 1500 East Medical Center Drive, 2120 Taubman Center, Box 0348, Ann Arbor, MI, 48109-0348

    Steven F. Bolling

Authors
  1. Steven F. Bolling
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bolling, S.F. Mitral Valve Reconstruction in the Patient with Heart Failure. Heart Fail Rev 6, 177–185 (2001). https://doi.org/10.1023/A:1011421014480

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011421014480

Search

Navigation